skip to Main Content

OUR TEAM

JEFF RENWICK
CEO

• Former President/CEO of Orbus Pharma
• Business Development for Indukern Chemie AG
• Extensive experience in drug formulation and business development

RICHARD GOLDSTEIN
CFO

• Founder of First Republic Capital
• Co-Founder Fraser McKenzie, former EVP and Head of IB at Standard Securities
• With 28 years of experience in Investment Banking, Research, Sales and Trading
• MBA in Finance from McMaster University

TOMMY LAROCQUE
PROCUREMENT

• More than 15 years of experience in Pharmaceuticals
• Previously was Procurement Manager and Compliance officer for Orbus Pharma inc.
• More than 15 year of Pharmaceutical plant GMP construction experience.

ROBERT LEFLER
DIRECTOR OF OPERATIONS

• 25+ years experience in the manufacturing of Pharmaceutical APIs, Finished Doses, Nutraceuticals and Cosmetics.
• Specializes in optimizing processes to allow for scaling up production within a given timeframe, credited with developing 40 lotions and creams.

ERIC MALINSKI
DIRECTOR OF MARKETING

• Education in marketing, and the neuropsychology of attention from the University of Toronto
• Experience as the Director of Marketing at one of Mississauga’s largest real estate brokerages
• President of The Full Stack inc.

DR. ERIC HATASHITA
ADVISORY BOARD

• Former Chief Resident, Mt. Sinai Hospital, Toronto.
• Former Family Physician to Saudi Royal Family.
• Founder, Regal Health Services.

BARRY M. POLISUK
CHAIRMAN

• Partner of Garfinkle, Biderman LLP
• Specialized in complex corporate transactions and corporate securities.
• LL.N. cum laude and a Quebec Civil Law degree, both from the University of Ottawa.

VITOR FONSECA
AUDIT COMMITTEE

• Vice President and Treasurer of Rompsen Investment Corp. and former Audit Committee Chair of Enwave Energy Corp.
• Audit Committee Chair of Mission Ready Services.
• MBA, CPA – CGA and member of The Institute of Corporate Directors.

BOB WOLOSCHUK
ADVISORY BOARD

• President of BLM Marketing Management.
• Over 20 years of pharmaceutical executive experience with a successful track record in business development.
• An expert in licensing strategies, both in Canada and international markets.

SABRINA RAMKELLAWAN
ADVISORY BOARD

• Vice President, The Clinical Research Association of Canada.
• President, Canadian Institute for Medical Advancement.
• 20 years experience in clinical trials, including 7 studies on Cannabinoids, establishing her as a leader in the field.

LORNE GERTNER
ADVISORY BOARD

Lorne Gertner has experience on the boards of a number of publicly traded cannabis companies, including Hiku Brands Company, and has developed a global network of contacts in the cannabis industry.

HAMISH SUTHERLAND
ADVISORY BOARD

• Founding COO of Bedrocan Canada, which was acquired by Tweed, now Canopy, delivering over $400 million in shareholder returns.
• Responsible for first legal transfer of live cannabis plant material from Holland to Canada.
• A professional engineer with an MBA from Schulich.

CONTACT US

Interested in what we do? Want to learn more about the opportunities we offer? Get in touch, enter your information and ask any questions you may have. We'll be sure to respond as soon as possible.

You can also reach us at Info@Canntab.ca

DISCLAIMER

This presentation contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur”, or “be achieved”. Forward-looking information is based on the opinions and estimates of management at the date the information is made, and is based on a number of assumptions and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including risks related to market and financing conditions as well as risks associated with the industries in which the Company operates, changes in project parameters as plans continue to be refined as well as other risk factors.  Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information contained herein.

Back To Top